Sanofi wins FDA nod for injectable multiple myeloma therapy
Seeking Alpha ·
Sanofi ( SNY ) on Friday announced FDA approval of a subcutaneously delivered version of its multiple myeloma therapy Sarclisa, which is currently available as an intravenous formulation in the U.S. The new formulation, branded as Sarclisa Escena, will therefore be indicated in the
DYAX Investor Sentiment
Bullish (Long) 50% · Bearish (Short) 50%
590 participants
Related News
- Wall Street trades relatively muted at the end of the week
- A Schwab account engaged in bulk of President Trump's trading in past year - report
- Trump 2.0 is outperforming historical presidential market cycles
- ClearBridge Global Infrastructure Income Strategy adds DTM; exits PEG, MAQAF, SSEZF
- European Commission finds Meta's Facebook and Instagram to be addictive
- Stock Market Today: Dow Jones Index Rises Ahead Of SK Hynix Stock Debut (Live Coverage)